An adrenal incidentaloma that had appeared to produce dehydroepiandrosterone-sulfate in excess before immunohistochemical study of the tumor.


Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
30 Jan 2023
Historique:
pubmed: 29 9 2022
medline: 1 2 2023
entrez: 28 9 2022
Statut: ppublish

Résumé

Adrenal incidentaloma is a clinically unapparent adrenal mass more than one cm in diameter detected during imaging performed not for adrenal disease. A 34-year-old man was evaluated for AI with a diameter of 3.5 cm in the left adrenal. He was obese with body mass index of 33,9. Blood pressure was 110-120/90 mmHg. The general laboratory tests were unremarkable. An adrenal hormone screening set revealed that ACTH was 6.9 pg/mL, cortisol 14.9 μg/dL, renin activity 0.9 ng/mL/h, aldosterone 79.4 pg/mL, dehydroepiandrosterone-sulfate (DHEA-S) measured on two occasions 5,217 ng/mL and 6,477 ng/mL (gender- and age-adjusted reference values, 1,060-4,640 ng/mL). The levels of metanephrine and normetanephrine were normal. The tumor was thought to produce solely DHEA-S. The excised left adrenal tissue contained a tumor with a diameter of 26 mm and neighboring adrenal tissue. The tumor consisted mostly of acidophil cells without necrosis, capsular or vascular invasion, and mitosis. Immunohistochemical study revealed followings: the cells of the tumors were stained positive for 3β-hydroxysteroid dehydrogenase, and 17α-hydroxylase, and 11β-hydroxylase, weakly positive for DHEA sulphotransferase, and negative for aldosterone synthetase. The atrophy of neighboring tissue was presumably caused by excess cortisol production. Four months after surgery, the cortisol level was 11.2 μg/dL and DHEA-S level 1,462 ng/mL. The tumor is considered to be a cortisol-producing adenoma with modestly excessive DHEA-S production rather than isolated DHEA-S-producing adenoma. Immunohistochemical study of steroidogenic enzymes is a valuable addition to blood hormone measurement to clarify steroid production profile.

Identifiants

pubmed: 36171143
doi: 10.1507/endocrj.EJ22-0116
doi:

Substances chimiques

Dehydroepiandrosterone Sulfate 57B09Q7FJR
Hydrocortisone WI4X0X7BPJ
Aldosterone 4964P6T9RB
Mixed Function Oxygenases EC 1.-
Sulfates 0
Dehydroepiandrosterone 459AG36T1B

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

43-46

Auteurs

Toshihide Yamamoto (T)

Department of Internal Medicine, Yao Tokushukai General Hospital, Osaka 581-0011, Japan.

Takuma Kimura (T)

Department of Surgery, Yao Tokushukai General Hospital, Osaka 581-0011, Japan.

Yuki Kubo (Y)

Department of Pathology, Yao Tokushukai General Hospital, Osaka 581-0011, Japan.

Shin-Ichi Nakatsuka (SI)

Department of Pathology, Yao Tokushukai General Hospital, Osaka 581-0011, Japan.

Hiromasa Harada (H)

Department of Internal Medicine, Yao Tokushukai General Hospital, Osaka 581-0011, Japan.

Takashi Suzuki (T)

Department of Pathology, Tohoku University Graduate School of Medicine, Miyagi 980-8574, Japan.

Hironobu Sasano (H)

Department of Pathology, Tohoku University Graduate School of Medicine, Miyagi 980-8574, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH